Ocular Therapeutix (OCUL) Interest & Investment Income: 2013-2025
Historic Interest & Investment Income for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to $3.7 million.
- Ocular Therapeutix's Interest & Investment Income fell 34.04% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 8.14%. This contributed to the annual value of $20.3 million for FY2024, which is 409.21% up from last year.
- Ocular Therapeutix's Interest & Investment Income amounted to $3.7 million in Q3 2025, which was up 7.93% from $3.5 million recorded in Q2 2025.
- Ocular Therapeutix's 5-year Interest & Investment Income high stood at $6.0 million for Q2 2024, and its period low was $6,000 during Q4 2021.
- Over the past 3 years, Ocular Therapeutix's median Interest & Investment Income value was $3.7 million (recorded in 2025), while the average stood at $3.2 million.
- In the last 5 years, Ocular Therapeutix's Interest & Investment Income plummeted by 91.37% in 2021 and then surged by 6,950.00% in 2022.
- Over the past 5 years, Ocular Therapeutix's Interest & Investment Income (Quarterly) stood at $6,000 in 2021, then soared by 6,950.00% to $423,000 in 2022, then skyrocketed by 244.92% to $1.5 million in 2023, then surged by 220.15% to $4.7 million in 2024, then plummeted by 34.04% to $3.7 million in 2025.
- Its Interest & Investment Income was $3.7 million in Q3 2025, compared to $3.5 million in Q2 2025 and $3.8 million in Q1 2025.